Fred Hutch Cancer Center researchers are always seeking better ways to prevent, detect and treat thyroid cancer. We are also working to better understand the factors that affect each person’s risk for this cancer. Our scientists are developing new methods to gauge how well a tumor will respond to treatment.
Physician-researchers at Fred Hutch are running many clinical trials of new drugs and drug combinations to treat different types of thyroid cancer. This type of research involves using experimental therapies that are part of a trend toward precision cancer care. The idea behind precision care is to target a patient’s tumor based on its molecular profile. We continue to hunt for more potential targets on thyroid cancer cells that could lead to even more treatment options.
Thyroid Cancer Clinical Trials
Fred Hutch typically has over 750 active cancer clinical trials enrolling participants.
Clinical trials may allow some patients access to a promising new treatment, and help physicians and researchers learn more about a disease.
Our Thyroid Cancer Researchers and Faculty
Our scientists and providers work together to prevent, diagnose and treat thyroid cancer as well as other cancers and diseases. Their lab research and clinical research are essential parts of the scientific process that leads to new treatments and better care. Many of our thyroid cancer providers also do research in addition to seeing patients. Participating in clinical trials can be a way for patients to get early access to new leading-edge therapies. Our research teams are running many clinical studies for people with thyroid cancer.
See below for our researchers and faculty or view our thyroid cancer care team providers.
